Estela Rodriguez, Associate Director of Community Outreach in Thoracic Oncology at the University of Miami’s Sylvester Comprehensive Cancer Center, shared Lung Cancers Today’s post on X, adding:
“More data presented by Solange Peters debunking the concept that time of day of Immunotherapy administration determines outcomes.
What really determines lung cancer outcomes is the access to the right treatment without delays, not the time of day.”
Quoting Lung Cancers Today‘s post:
“In case you missed it: ICI administration time of day is ‘unlikely to be a critical determinant of outcomes’ in patients with lung cancer, according to data from the ETOP-Roche i-TIMES study presented by Solange Peters of Centre Hospitalier Universitaire Vaudois (CHUV) at ELCC 26.”
Other articles featuring Estela Rodriguez and Lung Cancers Today on OncoDaily.